Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 12
Submit an article Journal homepage
52
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Recent findings into the potential of gene therapy to reverse heart failure

Sven T Pleger Thomas Jefferson University, Center for Translational Medicine, 1025 Walnut Street, Room 410, Philadelphia, Pennsylvania 19107, USA +1 215 955 9982; +1 215 503 5728; [email protected]; Universitãt zu Heidelberg, Medizinische Universitãtsklinik und Poliklinik III, Otto Meyerhof Zentrum, INF 350, 69115 Heidelberg, Germany
, MD,
Patrick Most Thomas Jefferson University, Center for Translational Medicine, 1025 Walnut Street, Room 410, Philadelphia, Pennsylvania 19107, USA +1 215 955 9982; +1 215 503 5728; [email protected]
, MD &
Walter J Koch Thomas Jefferson University, Center for Translational Medicine, 1025 Walnut Street, Room 410, Philadelphia, Pennsylvania 19107, USA +1 215 955 9982; +1 215 503 5728; [email protected]
, PhD
Pages 1781-1784 | Published online: 22 Nov 2007

Bibliography

  • Heart Disease and Stroke Statistics. American Heart Association, Dallas, TX, USA (2007).
  • FELDMAN DS, CARNES CA, ABRAHAM WT, BRISTOW MR: Mechanisms of disease: β-adrenergic receptors-alterations in signal transduction and pharmacogenetics in heart failure. Nat. Clin. Pract. Cardiovasc. Med. (2005) 2:475-483.
  • HASENFUSS G, PIESKE B: Calcium cycling in congestive heart failure. J. Mol. Cell. Cardiol. (2002) 34:951-969.
  • WILLIAMS M-L, HATA J-A, SCHRODER J et al.: Targeted β-adrenergic receptor kinase (bARK1) inhibition by gene transfer in failing human hearts. Circulation (2004) 109:1590-1593.
  • WHITE D-C, HATA J-A, SHAH A-S et al.: Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc. Natl. Acad. Sci. USA (2000) 97:5428-5433.
  • DEL MONTE F, HARDING S-E, DEC G-W, GWATHMEY J-K, HAJJAR R-J: Targeting phospholamban by gene transfer in human heart failure. Circulation (2002) 105:904-907.
  • MIYAMOTO M-I, DEL MONTE F, SCHMIDT U et al.: Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc. Natl. Acad. Sci. USA (2000) 97:793-798.
  • IWANAGA Y, HOSHIJIMA M, GU Y et al.: Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J. Clin. Invest. (2004) 113:727-736.
  • BRAZ J-C, GREGORY K, PATHAK A et al.: PKC-α regulates cardiac contractility and propensity toward heart failure. Nat. Med. (2004) 10:248-254.
  • PRESTLE J, JANSSEN P-M, JANSSEN A-P et al.: Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. Circ. Res. (2001) 88:188-194.
  • MOST P, BERNOTAT J, EHLERMANN P et al.: S100A1: a regulator of myocardial contractility. Proc. Natl. Acad. Sci. USA (2001) 98:13889-13894.
  • MOST P, REMPPIS A, PLEGER S-T et al.: Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J. Biol. Chem. (2003) 278:33809-33817.
  • MOST P, PLEGER S-T, VOLKERS M et al.: Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J. Clin. Invest. (2004) 114:1550-1563.
  • DONSANTE A, MILLER D-G, LI Y et al.: AAV vector integration sites in mouse hepatocellular carcinoma. Science (2007) 317:477.
  • PLEGER S-T, MOST P, BOUCHER M et al.: Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation (2007) 115:2506-2515.
  • KATZ A: Potential deleterious effects of inotropic reagents in the therapy of chronic heart failure. Circulation (1986) 73:III-184-III-190 (Abstract).
  • JANOSI A, GHALI J-K, HERLITZ J et al.; FOR THE MERIT-HF STUDY GROUP: Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF. Am. Heart J. (2003) 146:721-728.
  • CHEN Y, ESCOUBET B, PRUNIER F et al.: Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias. Circulation (2004) 109:1898-1903.
  • SASANO T, KIKUCHI K, MC DONALD A-D, LAI S, DONAHUE J-K: Targeted high-efficiency, homogeneous myocardial gene transfer. J. Mol. Cell. Cardiol. (2007) 42:954-961.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.